Chronic Inflammation: The Evidence-Based Supplement Protocol

← Back to articles

"Chronic inflammation" is a description, not a diagnosis. Low-grade elevations in C-reactive protein (CRP), interleukin-6 (IL-6), and tumour necrosis factor-alpha (TNF-α) track with cardiovascular, metabolic, and neurodegenerative risk, but they are markers of many different underlying processes — visceral adiposity, poor sleep, smoking, infection, or an autoimmune disease — rather than a single treatable target. The first caution of this protocol is therefore to be sceptical of treating a lab number. The interventions with the largest effect on systemic inflammation are not supplements at all: losing visceral fat, exercising, stopping smoking, sleeping enough, and eating a predominantly whole-food, plant-rich diet. A few supplements add a modest, genuine, measurable signal on top of that foundation. Below, the best-evidenced first.

Curcumin (bioavailable form), ~500 mg/day — the strongest supplement signal

Of the popular "anti-inflammatory" supplements, curcumin has the most consistent biomarker data. A 2023 GRADE-assessed dose-response meta-analysis of 66 randomized controlled trials (RCTs) found that curcumin/turmeric supplementation significantly lowered CRP (weighted mean difference −0.58 mg/L), TNF-α (−3.48 pg/mL), and IL-6 (−1.31 pg/mL), with no significant change in IL-1β. An earlier 2021 meta-analysis in Nutrition Reviews reached the same qualitative conclusion. Two honest caveats temper this. First, the absolute effects are small: a CRP drop of roughly half a milligram per litre is real on a population level but unlikely to be life-changing for an individual, and the trials were heterogeneous, ran mostly 8–12 weeks, and frequently enrolled people with metabolic or inflammatory conditions rather than healthy adults. Second, bioavailability is the rate-limiting step — most plain turmeric powder is poorly absorbed, so trials use enhanced formulations (with piperine, or formulated as phytosomes or nanoparticles). A typical studied dose is around 500 mg/day of a bioavailable preparation. Curcumin is an adjunct, not a substitute for disease-modifying therapy in an active inflammatory disease.

Omega-3 (EPA/DHA), ~2 g/day — modest, population-dependent

Marine omega-3 fatty acids genuinely shift inflammatory signalling, but the effect on circulating CRP is inconsistent. In a meta-analysis of 17 RCTs in cancer patients, omega-3 supplementation was associated with lower CRP, while a meta-analysis in chronic heart failure found significant reductions in TNF-α, IL-1, and IL-6 but no significant change in hsCRP — with larger effects above roughly 1 g/day and beyond four months. That split is the key nuance: omega-3 reliably moves some cytokines, less reliably moves CRP itself, and helps most in people with elevated baseline inflammation rather than already-healthy adults. A typical dose is roughly 2 g combined EPA + DHA daily, and high-quality, low-oxidation products matter because rancid fish oil is itself pro-oxidant. Omega-3 has independent cardiovascular and triglyceride-lowering roles, but for the narrow goal of "lowering inflammation" it is a modest adjunct, not a CRP-lowering drug.

Vitamin D — correct a deficiency, do not chase the number

Low 25-hydroxyvitamin D correlates with higher inflammatory markers in observational data, and supplementation produces modest biomarker improvements in some randomized trials — for example, a 2024 meta-analysis reported reductions in inflammatory biomarkers with vitamin D in patients with asthma. But the benefit concentrates in people who are genuinely deficient; in already-replete adults the inflammatory effect is small or absent. Test 25-hydroxyvitamin D and repletion to sufficiency with vitamin D3 if low, rather than dosing blindly to push a lab value.

A Mediterranean dietary pattern (including olive polyphenols)

The most durable "anti-inflammatory" evidence is dietary, not from a capsule. In a PREDIMED sub-study, a Mediterranean diet supplemented with extra-virgin olive oil or nuts improved biomarkers of vascular-wall inflammation versus a control diet in adults at high cardiovascular risk. Extra-virgin olive oil delivers polyphenols such as hydroxytyrosol; consistent with that, a meta-analysis found that anti-inflammatory dietary patterns lowered pain in rheumatoid arthritis (though the underlying trials were small and low-quality). The signal is real but modest, and it is the overall pattern — not any single polyphenol pill — that carries the evidence.

What doesn't work, or is overhyped

"Anti-inflammatory" detox teas, proprietary blends, and antioxidant megadoses have no credible CRP-lowering evidence, and high-dose antioxidants can be counterproductive. Isolated polyphenol or "anthocyanin" megadose capsules are far weaker than the dietary pattern they are marketed to replace. And no supplement here is strong enough to replace NSAIDs, DMARDs, or other prescribed therapy in an active inflammatory or autoimmune disease; using them instead of effective treatment can let real disease progress unchecked. Curcumin and high-dose omega-3 have mild antiplatelet effects, so flag them to your clinician if you take anticoagulants or are approaching surgery. The broader trap is the "anti-inflammatory" framing itself: it treats a diverse set of biological processes as one thing, and sells capsules against a number rather than against a diagnosis.

How to run the protocol

Start with the basics that actually move inflammation: address body composition, sleep, physical activity, smoking, and alcohol, and shift toward a Mediterranean-style dietary pattern. These produce far larger and more durable effects than any capsule, and they are also what the strongest evidence (the PREDIMED dietary trials) actually tested. If you and your clinician want a supplement layer on top, a defensible stack is bioavailable curcumin ~500 mg/day plus omega-3 ~2 g/day, with vitamin D added only to correct a measured deficiency. If you track hsCRP, interpret it cautiously: it swings with infections, recent injury, hard exercise, and weight change, so a single value means little and trends over months mean more. Critically, a high CRP is a clue, not a diagnosis — persistent elevation without an obvious cause warrants medical evaluation for an underlying driver (occult infection, an autoimmune disease, or cardiovascular risk), not an ever-larger pile of anti-inflammatory pills. Treat the cause, not the number.